630 related articles for article (PubMed ID: 23484708)
41. Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population: A Case Series and Review of the Literature.
Nguyen CM; Stuart L; Skupsky H; Lee YS; Tsuchiya A; Cassarino DS
Am J Dermatopathol; 2015 Dec; 37(12):924-8. PubMed ID: 26588336
[TBL] [Abstract][Full Text] [Related]
42. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm with Orbital Tumor as the Initial Symptom.
Li P; Pang N; Li M; Xie J; Wang Y
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623681
[TBL] [Abstract][Full Text] [Related]
43. Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.
Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA
Curr Hematol Malig Rep; 2017 Dec; 12(6):592-597. PubMed ID: 29064025
[TBL] [Abstract][Full Text] [Related]
44. An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor.
Pak DM; Tretiakova MS
Case Rep Pathol; 2019; 2019():9196167. PubMed ID: 31687245
[TBL] [Abstract][Full Text] [Related]
45. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
46. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.
Nasiri A; Lami A; Alhumaidi A; Madkhali A; Althaqib A; Aljarwan N; Alkharras R
Cureus; 2023 Apr; 15(4):e37016. PubMed ID: 37026111
[TBL] [Abstract][Full Text] [Related]
47. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
48. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen.
Inoue D; Maruyama K; Aoki K; Nagano S; Maruoka H; Imai Y; Ito K; Ishikawa T; Takahashi T
Acta Haematol; 2011; 126(2):122-8. PubMed ID: 21701157
[TBL] [Abstract][Full Text] [Related]
49. [Blastic plasmacytoid dendritic cell neoplasm (BPDCN) : A rare hematologic neoplasm with frequent cutaneous involvement].
Nguyen K; Korsing S; Mansour Y; Meier K
Dermatologie (Heidelb); 2023 Oct; 74(10):787-792. PubMed ID: 37407876
[TBL] [Abstract][Full Text] [Related]
50. First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.
Sun W; Liu H; Kim Y; Karras N; Pawlowska A; Toomey D; Kyono W; Gaynon P; Rosenthal J; Stein A
J Hematol Oncol; 2018 May; 11(1):61. PubMed ID: 29720227
[TBL] [Abstract][Full Text] [Related]
51. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract][Full Text] [Related]
52. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
[TBL] [Abstract][Full Text] [Related]
53. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.
Dang X; Zhou D; Meng L; Bi L
J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792
[TBL] [Abstract][Full Text] [Related]
54. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
Adimora IJ; Wilson NR; Pemmaraju N
Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525
[TBL] [Abstract][Full Text] [Related]
55. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
[TBL] [Abstract][Full Text] [Related]
56. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
[TBL] [Abstract][Full Text] [Related]
57. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm, Clinical Features and Immunophenotype: A Case Report.
Suárez A; Soler N; Calderon A; Martinez B; Piña M
Cureus; 2023 Feb; 15(2):e34549. PubMed ID: 36879711
[TBL] [Abstract][Full Text] [Related]
58. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.
Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE
Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581
[TBL] [Abstract][Full Text] [Related]
59. Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.
Ohe R; Aung NY; Shiono Y; Utsunomiya A; Kabasawa T; Tamazawa N; Tamura Y; Kato T; Yamada A; Hasegawa S; Aizawa K; Inokura K; Ito S; Toubai T; Kato Y; Tsunoda T; Onami K; Suzuki T; Ishizawa K; Yamakawa M
J Clin Exp Hematop; 2018 Mar; 58(1):1-9. PubMed ID: 29415975
[TBL] [Abstract][Full Text] [Related]
60. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.
Wang H; Cao J; Hong X
Acta Haematol; 2012; 127(2):124-7. PubMed ID: 22236870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
